Huntingdon, United Kingdom

Julie Belinda Warneck

This inventor holds 1 USPTO granted patent. Top assignees: Chirotech Technology Limited, Laboratorios Menarini S.a.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julie Belinda Warneck. Retrieved from https://idiyas.com/inventor/julie-belinda-warneck

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Julie Belinda Warneck

Introduction

Julie Belinda Warneck is a notable inventor based in Huntingdon, GB. She has made significant contributions to the field of biochemistry, particularly in the area of stereoselective hydrolysis. Her work has implications for the production of enantiomeric compounds, which are crucial in various pharmaceutical applications.

Latest Patents

Julie holds a patent for the "Stereoselective hydrolysis of chiral carboxylic acid esters using an organism of the genus Ophiostoma or Ceratocystis, or a material having enzymatic activity derived therefrom." This innovative method utilizes a stereo-specific agent in a biotransformation reaction to produce an enantiomeric acid or alcohol from a mixture of enantiomers of an ester. She has 1 patent to her name, showcasing her expertise in this specialized area.

Career Highlights

Throughout her career, Julie has worked with prominent companies, including Laboratorios Menarini S.A. and Chirotech Technology Limited. Her experience in these organizations has allowed her to apply her innovative ideas in practical settings, contributing to advancements in biochemistry and related fields.

Collaborations

Julie has collaborated with Richard Anthony Wisdom, further enhancing her research and development efforts. Their partnership has likely led to fruitful discussions and innovative solutions in their respective areas of expertise.

Conclusion

Julie Belinda Warneck is a pioneering inventor whose work in stereoselective hydrolysis has the potential to impact the pharmaceutical industry significantly. Her contributions and collaborations reflect her commitment to advancing scientific knowledge and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…